- CEO
- Jamal Sabsabi
- Full Time Employees
- 29
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 3/886 Woodville Road Villawood Australia 2163
- IPO Date
- Dec 5, 2011
- Business
- Freedom Care Group Holdings Limited (ASX:FCG) provides National Disability Insurance Scheme (NDIS) care and support services to individuals with disabilities across Australia, with a focus on complex cases requiring intensive assessment, planning, coordination and monitoring; core offerings encompass Core Supports for everyday activities and goal achievement, Capacity Building Supports including support coordination, social and community participation and school leaver employment supports, Capital Supports featuring assistive technology, equipment, home and vehicle modifications, Supported Independent Living with respite, medium-term and long-term accommodation options, allied health and therapeutic services such as speech therapy, occupational therapy, psychology and behaviour support, physiotherapy, podiatry, dietetics, exercise physiology and chiropractic, Plan Management, custom-built Day Programs for skill-building in daily living and social confidence, and home and community participation services. The company, founded in 1993 and headquartered at Shop 3, 886 Woodville Road, Villawood, New South Wales, primarily operates in the greater Sydney area with expansion into regions like the mid-North Coast of New South Wales and plans for interstate growth into Melbourne, Brisbane and Perth through organic development and strategic mergers and acquisitions targeting entities with turnover exceeding A$3m, ethical compatibility and organic growth potential. In November 2023, Freedom Care Group Holdings Ltd listed on the ASX following its initial public offering and acquired 100% of Freedom Care Corporation Pty Ltd and controlled entities, transitioning principal activities to full NDIS operations and reporting FY24 revenue of A$32.8m, up 38.8% year-on-year, with 95% from Australian Government sources, cash flow positivity in the second half despite one-off IPO costs, and a debt-free balance sheet supporting further scaling in the complex NDIS segment amid projected scheme expenditure growth to A$60.75b by FY28.